Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

Todd Neale

February 27, 2025

News Daily News

Bempedoic Acid Gains CV Risk Reduction Indication

Todd Neale

March 22, 2024

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Daily News

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Yael L. Maxwell

October 19, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2023

Shelley Wood

March 30, 2023

News Daily News

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

Michael O'Riordan

March 01, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Caitlin E. Cox

August 31, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

Female Cardiologists Still Face Pushback as Physician-Researchers

Caitlin E. Cox

February 28, 2022

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Daily News

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Yael L. Maxwell

July 07, 2020

News Daily News

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

Shelley Wood

February 26, 2020

News Daily News

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

Michael O'Riordan

March 15, 2019

News Daily News

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

Shelley Wood

October 29, 2018

News Daily News

Bempedoic Acid Phase III Trial Meets Primary Endpoint for Cutting LDL Cholesterol

Yael L. Maxwell

March 08, 2018

Advertisement

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

ACC/AHA Release New Comprehensive ACS Guidelines

Bempedoic Acid Gains CV Risk Reduction Indication

Top General Cardiology and CVD Prevention News of 2023

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

LDL Control Remains Poor in CAD Patients: NHANES

TCTMD’s Top 10 Most Popular Stories for March 2023

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Good News and Bad for High-Intensity Statin Use in ASCVD

Female Cardiologists Still Face Pushback as Physician-Researchers

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

Bempedoic Acid Phase III Trial Meets Primary Endpoint for Cutting LDL Cholesterol

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content